Table 2.
MIC of antibiotics against Staphylococcal isolates of those species, which showed multidrug resistance in the DBRACL
| Staphylococci isolates | Strain ID | Antibioticsa | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Minimum inhibitory concentrations (μg/mL) | |||||||||
| Oxa | Tet | Ery | Clin | Cip | Amp | Genta | |||
| Human associated | S. haemolyticus | S24 | 1 (R) | ≤ 0.5(S) | >32 (R) | < 0.0625(S) | 0.5(S) | 0.5 (R) | < 0.0625(S) |
| S41 | 0.25(S) | 16 (R) | 32 (R) | 4 (R) | >32 (R) | 8 (R) | 0.25(S) | ||
| S43 | 0.5 (R) | ≤ 0.5(S) | 0.25(S) | 4 (R) | 0.5(S) | 0.25(S) | 0.125(S) | ||
| S53 | 4 (R) | 16 (R) | 0.5(S) | 4 (R) | 0.5(S) | >32 (R) | < 0.5(S) | ||
| S. cohnii | S6 | 0.5 (R) | ≤ 0.5(S) | >32 (R) | >32 (R) | 1(S) | 0.25(S) | < 0.5(S) | |
| S14 | 0.25(S) | ≤ 0.5(S) | 64 (R) | >32 (R) | 0.5(S) | 0.25(S) | < 0.0625(S) | ||
| S22 | 0.5 (R) | ≤ 0.5(S) | 8 (R) | 0.25(S) | 32 (R) | 1 (R) | < 0.0625(S) | ||
| S. hominis | S21 | 0.125(S) | ≤ 0.5(S) | 32 (R) | < 0.0625(S) | 1(S) | 0.25(S) | 16 (R) | |
| S45 | 16 (R) | ≤ 0.5(S) | 8 (R) | < 0.0625(S) | >32 (R)) | 0.5 (R) | < 0.5(S) | ||
| S. epidermidis | S52 | 0.25(S) | ≤ 0.5(S) | >32 (R) | < 0.0625(S) | 0.25(S) | 4 (R) | < 0.5(S) | |
| Animal associated | S. xylosus | S17 | 0.5 (R) | ≤ 0.5(S) | >32 (R) | < 0.0625(S) | 0.25(S) | 0.125(S) | < 0.5(S) |
| S27 | 0.125(S) | ≤ 0.5(S) | 32 (R) | < 0.0625(S) | 1(S) | 8 (R) | 0.5(S) | ||
| S37 | 0.125(S) | ≤ 0.5(S) | 8 (R) | < 0.0625(S) | 0.25(S) | 2 (R) | 1(S) | ||
| S47 | 2 (R) | ≤ 0.5(S) | 1 (I) | < 0.0625(S) | >32 (R) | 16 (R) | 0.125(S) | ||
| S. lentus | S15 | 0.5 (R) | ≤ 0.5(S) | 0.25(S) | 0.25(S) | >32 (R) | 0.25(S) | 0.0625(S) | |
| S49 | 0.25(S) | ≤ 0.5(S) | >32 (R) | 0.125(S) | 0.25(S) | 0.5 (R) | < 0.0625(S) | ||
aOxa Oxacillin, Tet Tetracycline, Ery Erythromycin, Clin Clindamycin, Cip Ciprofloxacin, Amp Ampicillin, Genta Gentamicin, S Sensitive, I Intermediate, R Resistant